Overdosing on Chemo: A Common Gene Test Could Save Hundreds of Lives Each Year
The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.
Stay updated with breaking news from Mark Fleury. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.
Treatment can be deadly for enzyme-deficient patients; NCCN doesn't call for preemptive testing
In honor of World Cancer Day, we highlighted ongoing and successful advocacy efforts in the oncology space.
Biopharma clinical trial sponsors want to speed up trials through targeted actions to improve patient and site engagement and enrollment productivity
Chief Judge Roberto A. Lange, U.S. District Court, has sentenced a Fort Thompson, South Dakota, man convicted ...